Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) vs Guyana: Proportion of the target population who received a 3rd dose of
Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)
84.0%
in 2024
Guyana
98.0%
in 2024
Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) rank
6th
Guyana rank
7th
Proportion of the target population who received a 3rd dose of over time
- Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)
- Guyana
How they compare
Guyana currently reports 98.0% against 84.0% in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand), a difference of 14.0%.
That makes Guyana's figure about 1.2 times Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)'s.
The two have swapped places 1 time across 14 shared years of data; in 2011 it was Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) ahead.
Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) ranks 6th and Guyana ranks 7th of 37 groups.
Guyana has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) | Guyana | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 70.4% | 89.4% | 19.0% | Guyana |
| 2020s | 83.6% | 95.8% | 12.2% | Guyana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) or Guyana?
- Guyana, at 98.0% against 84.0% in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) and Guyana?
- 14.0%, with Guyana ahead.
- How many years of comparable data are there for Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) and Guyana?
- 14 years are reported by both, from 2011 to 2024.
- How do Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) and Guyana rank globally for proportion of the target population who received a 3rd dose of?
- Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) ranks 6th and Guyana ranks 7th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.